Advertise
Ophthalmology Times® offers custom-designed programs to fit the needs of your brand. By utilizing our omnichannel marketing levers you will have access to our highly engaged audience and receive guaranteed, quality results.
Let's work together - Contact Us!
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
2
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
3
Expanding the ICRS toolkit: Keraring for high regular astigmatism
4
Study finds mixed real and synthetic eye images enhance ocular AI performance
5